Objective: To assess the diagnostic accuracy of whole-body MRI using diffusion-weighted sequence (WB-DWI) to determine the peritoneal cancer index (PCI) in correlation with surgical and histopathological findings. Methods: Twenty-seven patients underwent preoperative WB-MRI, followed by cytoreductive surgery for primary tumors of the appendix (n = 15), colorectum (n = 12), and associated peritoneal disease. A total of 351 regions were retrospectively reviewed. The sensitivity, specificity, and accuracy were calculated at 13 anatomical sites. The WB-DWI PCI and PCI type were compared with surgical and histopathological findings. Conclusions: WB-DWI accurately predicted PCI before surgery in patients undergoing evaluation for cytoreductive surgery.
Introduction
Peritoneal metastases (PM) refers to malignant metastasis involving the peritoneum in the abdominopelvic cavity with primary modes of spreading by hematogenous and implantation metastasis. For patients with gastrointestinal cancer, in addition to the result of full-thickness invasion of the bowel wall by an invasive cancer, preoperative seeding may also occur due to the rupture of structure (s) by a noninvasive tumor, such as less-invasive mucinous appendiceal cancers 1 . The presence of peritoneal disseminators has been historically associated with a very poor prognosis 2 .
The peritoneal cancer index (PCI), as reported by Jacquet and Sugarbaker 3 , quantitatively evaluates both cancer distribution and lesion size throughout the abdominopelvic region 4, 5 . The PCI score is not only considered to be an independent prognostic factor for patients with PM who are recommended to undergo surgical cytoreduction (CRS) and heated intraperitoneal chemotherapy (HIPEC), but also an important influencing factor determining whether complete macroscopic cytoreduction can be achieved 6 . An accurate preoperative PCI score assessment would be useful for appropriate treatment strategy selection and prognosis prediction.
Multidetector computed tomography (CT) was previously the most common preoperative staging and follow-up method for patients with PM. However, due to the limited soft tissue resolution of CT, its sensitivity for detecting small lesions noticeably decreases [7] [8] [9] . Equipped with high soft tissue resolution, MRI can use different types of image contrast to more accurately describe the distribution and extent of peritoneal tumor [10] [11] [12] [13] [14] [15] . Diffusion-weighted imaging (DWI) exploits the thermally driven motion of water molecules. Most tumors are characterized by the restricted diffusion of water molecules due to increased cellularity and disordered arrangement, and are highlighted on DWI as hyperintense signal.
We undertook the present study to evaluate the accuracy of WB-DWI for determining the extent of PM and its correlation with surgical and histopathological findings.
Materials and patients Patients
Between September 2015 and December 2017, a total of 27 patients with colorectal malignancy, in whom PM were known or suspected, and who were candidates for surgical exploration, were recruited into the study. The patients (13 women, 14 men) ranged in age from 27 to 67 years (mean, 51 years), and were confirmed histopathologically to have primary tumors of the appendix (n = 15) and colorectum (n = 12). The study protocol was approved by the authors' institutional review board, and all patients provided informed written consent.
MR imaging
All MRI examinations were performed using a 3T MRI scanner (MAGNETOM Skyra, Siemens Healthcare, Erlangen, Germany) equipped with a 16-channel phase-array body coil. The MRI protocol included two-step T1-weighted and T2-weighted sequences, with coverage of the abdominal and pelvic regions and multiple-step EPI DWI (prototype, iShim whole body DWI) sequence with coverage from the head to the pelvic cavity. Other parameters of WB-DWI included: TR/TE = 5600/60 ms; FOV = 480 × 330 mm 2 ; scan matrix = 128 × 128; slice thickness = 5 mm; b = 50, 800 s/mm 2 ; diffusion mode = 3D diagonal; slice-selective IR, with TI = 240 ms for fat suppression; iPAT factor = 2; and scan time = 2 mins, 14 sec/step.
Review of MRI
The MR images were reviewed by a radiologist with 13 years' experience in abdominal MRI. The reviewer was blind to all patient clinical information. Plaque-like areas of hyperintensity in the subphrenic regions, and focal nodular or mass areas of hyperintensity involving the peritoneum, omentum, mesentery or bowel serosa, were recorded as tumors on DWI with b = 800 s/mm 2 . The abdominal and pelvic intraperitoneal spaces of each patient were divided into nine regions and the small bowel was divided into four regions 6 . The reviewer recorded the presence or absence of metastatic peritoneal tumors and scored each of the 13 anatomical sites as follows: 0, no visible tumor; 1, tumor < 0.50 cm in greatest diameter; 2, tumor = 0.50-5.0 cm; and 3, tumor > 5.0 cm or confluence.
Following a blinded review of the MR examinations, the MRI results were compared with the results from the surgical and histopathological records. The sensitivity, specificity, and accuracy for identifying PM were calculated for each respective anatomical site. The PCI scores were categorized as follows: PCI = 0-10 (small-volume tumor); 10 < PCI < 20 (moderate-volume tumor); and PCI ≥ 20 (large-volume tumor). WB-DWI PCI and surgical PCI were compared using the paired t-test in SPSS version 21 (IBM Corporation, Armonk, NY, USA).
Results
A total of 351 anatomical sites were reviewed in this study, 203 of which were confirmed to comprise PM at surgery and histopathological analysis (47 lesions of adenocarcinoma in 9 patients, 140 lesions of mucinous adenocarcinoma in 15, and 16 lesions of signet ring cell carcinoma in 3). The lesion size was < 0.5 cm in 108 sites, 0.5-5.0 cm in 80 sites, and > 5.0 cm in the remaining 15 sites. WB-DWI correctly depicted tumors in 163 regions with 40 false-negative regions and 23 false-positive regions ( Table 1 , and Figures 1 and 2) . The overall sensitivity, specificity, and accuracy of WB-DWI for the detection of peritoneal tumors were 80.3%, 84.5%, and 82.1%, respectively. For lesions < 0.5 cm in diameter, DWI demonstrated good sensitivity (69.4%) ( Table 2) .
The PCI on preoperative WB-DWI and the corresponding surgical PCI score for all 27 patients are shown in Figure 3 . There was no statistical difference between the WB-DWI PCI and surgical PCI (P = 0.574). WB-DWI correctly predicted the PCI type in 24 of 27 patients with high accuracy (88.9%), including 10 of 10 patients with small-volume tumor, 12 of 14 with moderate volume tumor, and 2 of 3 with largevolume tumor ( Table 3) .
Discussion
Colorectal cancer patients with PM are traditionally believed to have poor prognosis and low-value prospective (PET-CT) was negative. PM was confirmed in the followed cytoreductive surgery along with the resection for primary lesion.
The PCI of preoperative WB-DWI and surgery were 13 and 18 respectively, with a same PCI Type.
surgical treatment. However, with the development of multidisciplinary treatment, a growing number of recent clinical studies indicate that CRS and HIPEC may improve the survival time and the quality of life of patients with PM [16] [17] [18] [19] . The PCI score, which represents the distribution of the tumor in the abdominopelvic regions and lesion size, is considered to be a prognostic factor for patients after CRS and HIPEC. Patients with low-volume peritoneal tumor could be more likely to benefit from CRS and HIPEC 20 . Some survival analyses have found that PCI score was closely related to patient survival 21, 22 . Patients with small-volume tumor (PCI < 10) achieved a higher 5-year survival rate than patients with a PCI ranging from 10 to 20, or > 20 (P < 0.05). PCI < 20 is recommended as one criterion of the principle of CRS and HIPEC in patients with colorectal peritoneal metastatic lesions 23, 24 . For patients with tumors that are too extensive and cannot be adequately cytoreduced, good preoperative imaging helps prevent unnecessary surgeries. This study aimed to contribute to careful patient selection criteria for CRS and HIPEC. CT used to be the most common preoperative staging method for patients with PM, but was limited by soft tissue resolution, and its sensitivity is not ideal when the size of the peritoneal lesion is < 1 cm 25, 26 . Preoperative PCI was significantly underestimated on CT comparing with surgical findings (P < 0.001), and small PM (< 0.5 cm) were visualized on CT with a sensitivity of only 11 %-48 % 4,9 . The low detection veracity rate of CT for small peritoneal tumors may result in underestimation of the extent of PM and the preoperative PCI score. With a high sensitivity for depicting the increased cellularity that characterizes most solid tumors, DWI helps to overcome these limitations and increase the detectability of even small malignant deposits 10,11,13 . Low et al. 27 reported that the accuracy in depicting peritoneal lesions was 95% for DWI, compared with 55% for CT, and that MRI more accurately predicted the PCI category preoperatively with high accuracy (91%).
These results are consistent with those of our study. We found that there was no statistical difference between the WB-DWI PCI and surgical PCI (P = 0.574). WB-DWI There were several potential limitations to our investigation, the first of which was its retrospective design. Second, due to the small number of enrolled patients, the applicability of our data need to be confirmed with a larger patient population. For the 10 patients with small-volume tumor, two had lesions > 5 cm, which may have somewhat overestimated the sensitivity of preoperative DWI in assessing patients with small-volume peritoneal tumor. Third, a direct comparison between DWI and CT was not undertaken in this study; we acknowledge that this would have been more conducive to confirming the superior performance of DWI in detecting peritoneal tumor.
Conclusions
Our results suggest that preoperative WB-DWI accurately predicts PCI in correlation with surgical and histopathological findings. The ability of preoperative WB-DWI to accurately predict the PCI score may assist oncologic surgeons to select patients who may benefit more from CRS and HIPEC, and exclude those whose tumors are too extensive and unlikely to achieve complete macroscopic cytoreduction. However, larger scale and prospective studies are needed to establish the clinical application.
